GPCR/G protein

All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
-   B6819 SB 206553 hydrochlorideSummary: 5-HT2B/5-HT2C receptor antagonist B6819 SB 206553 hydrochlorideSummary: 5-HT2B/5-HT2C receptor antagonist
-   C3003 (±)-TalinololSummary: β1-selective adrenoceptor antagonist C3003 (±)-TalinololSummary: β1-selective adrenoceptor antagonist
-   B6818 GR 125487 sulfamateSummary: 5-HT4 receptor antagonist B6818 GR 125487 sulfamateSummary: 5-HT4 receptor antagonist
-   B6815 Mesulergine hydrochlorideSummary: 5-HT2A and 2C receptor antagonist B6815 Mesulergine hydrochlorideSummary: 5-HT2A and 2C receptor antagonist
-   B7730 TC-G 1000Summary: α2D-adrenoceptor agonist B7730 TC-G 1000Summary: α2D-adrenoceptor agonist
-   B6776 LY 215840Summary: 5-HT2/5-HT7 receptor antagonist B6776 LY 215840Summary: 5-HT2/5-HT7 receptor antagonist
-   B7558 SR 58611A hydrochlorideSummary: β3-adrenergic receptor agonist B7558 SR 58611A hydrochlorideSummary: β3-adrenergic receptor agonist
-   B6754 GR 127935 hydrochlorideSummary: 5-HT1B/1D receptor antagonist B6754 GR 127935 hydrochlorideSummary: 5-HT1B/1D receptor antagonist
-   B7518 SKF 86466 hydrochlorideSummary: α2-adrenoceptor antagonist B7518 SKF 86466 hydrochlorideSummary: α2-adrenoceptor antagonist
-   B6729 NAS-181Summary: rat 5-HT1B receptor antagonist B6729 NAS-181Summary: rat 5-HT1B receptor antagonist
